-
Je něco špatně v tomto záznamu ?
Synergistic effect of leptin and lipidized PrRP on metabolic pathways in ob/ob mice
L. Kořínková, M. Holubová, B. Neprašová, L. Hrubá, V. Pražienková, M. Bencze, M. Haluzík, J. Kuneš, L. Maletínská, B. Železná
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články
NLK
Free Medical Journals
od 1997 do Před 12 měsíci
Freely Accessible Science Journals
od 1997 do Před 12 měsíci
Open Access Digital Library
od 1988-07-01
Open Access Digital Library
od 1997-09-01
PubMed
31855558
DOI
10.1530/jme-19-0188
Knihovny.cz E-zdroje
- MeSH
- glukózový toleranční test MeSH
- hormon uvolňující prolaktin analogy a deriváty chemie farmakologie terapeutické užití MeSH
- játra účinky léků metabolismus MeSH
- leptin farmakologie terapeutické užití MeSH
- metabolické sítě a dráhy účinky léků MeSH
- metabolismus lipidů účinky léků MeSH
- myši obézní MeSH
- myši MeSH
- obezita farmakoterapie metabolismus MeSH
- přijímání potravy účinky léků MeSH
- synergismus léků MeSH
- tělesná hmotnost účinky léků MeSH
- tělesná teplota MeSH
- zvířata MeSH
- Check Tag
- mužské pohlaví MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
Lack of leptin production in ob/ob mice results in obesity and prediabetes that could be partly reversed by leptin supplementation. In the hypothalamus, leptin supports the production of prolactin-releasing peptide (PrRP), an anorexigenic neuropeptide synthesized and active in the brain. In our recent studies, the palmitoylated PrRP analog palm11-PrRP31 showed a central anorexigenic effect after peripheral administration. This study investigates whether PrRP could compensate for the deficient leptin in ob/ob mice. In two separate experiments, palm11-PrRP31 (5 mg/kg) and leptin (5 or 10 μg/kg) were administered subcutaneously twice daily for 2 or 8 weeks to 8- (younger) or 16-(older) week-old ob/ob mice, respectively, either separately or in combination. The body weight decreasing effect of palm11-PrRP31 in both younger and older ob/ob mice was significantly powered by a subthreshold leptin dose, the combined effect could be then considered synergistic. Leptin and palm11-PrRP31 also synergistically lowered liver weight and blood glucose in younger ob/ob mice. Reduced liver weight was linked to decreased mRNA expression of lipogenic enzymes. In the hypothalamus of older ob/ob mice, two main leptin anorexigenic signaling pathways, namely, Janus kinase, signal transducer and activator of transcription-3 activation and AMP-activated protein kinase de-activation, were induced by leptin, palm11-PrRP31, and their combination. Thus, palm11-PrRP31 could partially compensate for leptin deficiency in ob/ob mice. In conclusion, the results demonstrate a synergistic effect of leptin and our lipidized palm11-PrRP31 analog.
1st Faculty of Medicine Charles University Prague Prague Czech Republic
Institute for Clinical and Experimental Medicine Prague Czech Republic
Institute of Physiology Academy of Sciences of the Czech Republic Prague Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21012889
- 003
- CZ-PrNML
- 005
- 20250924094550.0
- 007
- ta
- 008
- 210420s2020 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1530/JME-19-0188 $2 doi
- 035 __
- $a (PubMed)31855558
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Kořínková, Lucia $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic $u First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
- 245 10
- $a Synergistic effect of leptin and lipidized PrRP on metabolic pathways in ob/ob mice / $c L. Kořínková, M. Holubová, B. Neprašová, L. Hrubá, V. Pražienková, M. Bencze, M. Haluzík, J. Kuneš, L. Maletínská, B. Železná
- 520 9_
- $a Lack of leptin production in ob/ob mice results in obesity and prediabetes that could be partly reversed by leptin supplementation. In the hypothalamus, leptin supports the production of prolactin-releasing peptide (PrRP), an anorexigenic neuropeptide synthesized and active in the brain. In our recent studies, the palmitoylated PrRP analog palm11-PrRP31 showed a central anorexigenic effect after peripheral administration. This study investigates whether PrRP could compensate for the deficient leptin in ob/ob mice. In two separate experiments, palm11-PrRP31 (5 mg/kg) and leptin (5 or 10 μg/kg) were administered subcutaneously twice daily for 2 or 8 weeks to 8- (younger) or 16-(older) week-old ob/ob mice, respectively, either separately or in combination. The body weight decreasing effect of palm11-PrRP31 in both younger and older ob/ob mice was significantly powered by a subthreshold leptin dose, the combined effect could be then considered synergistic. Leptin and palm11-PrRP31 also synergistically lowered liver weight and blood glucose in younger ob/ob mice. Reduced liver weight was linked to decreased mRNA expression of lipogenic enzymes. In the hypothalamus of older ob/ob mice, two main leptin anorexigenic signaling pathways, namely, Janus kinase, signal transducer and activator of transcription-3 activation and AMP-activated protein kinase de-activation, were induced by leptin, palm11-PrRP31, and their combination. Thus, palm11-PrRP31 could partially compensate for leptin deficiency in ob/ob mice. In conclusion, the results demonstrate a synergistic effect of leptin and our lipidized palm11-PrRP31 analog.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a tělesná teplota $7 D001831
- 650 _2
- $a tělesná hmotnost $x účinky léků $7 D001835
- 650 _2
- $a synergismus léků $7 D004357
- 650 _2
- $a přijímání potravy $x účinky léků $7 D004435
- 650 _2
- $a glukózový toleranční test $7 D005951
- 650 _2
- $a leptin $x farmakologie $x terapeutické užití $7 D020738
- 650 _2
- $a metabolismus lipidů $x účinky léků $7 D050356
- 650 _2
- $a játra $x účinky léků $x metabolismus $7 D008099
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a metabolické sítě a dráhy $x účinky léků $7 D053858
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši obézní $7 D008820
- 650 _2
- $a obezita $x farmakoterapie $x metabolismus $7 D009765
- 650 _2
- $a hormon uvolňující prolaktin $x analogy a deriváty $x chemie $x farmakologie $x terapeutické užití $7 D056690
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Holubová, Martina $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic
- 700 1_
- $a Neprašová, Barbora $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic $7 xx0335496
- 700 1_
- $a Hrubá, Lucie $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic
- 700 1_
- $a Pražienková, Veronika $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic
- 700 1_
- $a Bencze, Michal, $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic $u Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic $d 1986- $7 av2016924515
- 700 1_
- $a Haluzík, Martin $u First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic $u Institute for Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Kuneš, Jaroslav $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic $u Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic
- 700 1_
- $a Maletínská, Lenka $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic
- 700 1_
- $a Železná, Blanka $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Prague, Czech Republic
- 773 0_
- $w MED00002809 $t Journal of molecular endocrinology $x 1479-6813 $g Roč. 64, č. 2 (2020), s. 77-90
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31855558 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20250924094545 $b ABA008
- 999 __
- $a ok $b bmc $g 1651129 $s 1133268
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 64 $c 2 $d 77-90 $e - $i 1479-6813 $m Journal of molecular endocrinology $n J Mol Endocrinol $x MED00002809
- LZP __
- $a Pubmed-20210420